128 related articles for article (PubMed ID: 7418404)
1. Endometrial estrogen and progestin receptors in women bearing a progesterone-releasing intrauterine device.
Jänne O; Ylöstalo P
Contraception; 1980 Jul; 22(1):19-23. PubMed ID: 7418404
[TBL] [Abstract][Full Text] [Related]
2. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system.
Critchley HO; Wang H; Kelly RW; Gebbie AE; Glasier AF
Hum Reprod; 1998 May; 13(5):1210-7. PubMed ID: 9647549
[TBL] [Abstract][Full Text] [Related]
3. Effects of a progesterone-releasing intrauterine contraceptive device on endometrial blood vessels: a morphometric study.
Shaw ST; Macaulay LK; Aznar R; González-Angulo A; Roy S
Am J Obstet Gynecol; 1981 Dec; 141(7):821-7. PubMed ID: 7315908
[TBL] [Abstract][Full Text] [Related]
4. Estrogen and progestin regulation of the progesterone receptor concentration in human endometrium.
Kreitmann B; Bugat R; Bayard F
J Clin Endocrinol Metab; 1979 Dec; 49(6):926-9. PubMed ID: 92478
[TBL] [Abstract][Full Text] [Related]
5. The effect of a levonorgestrel-releasing intrauterine device on human endometrial oestrogen and progesterone receptors after one year of use.
Zhu P; Liu X; Luo H; Gu Z; Cheng J; Xu R; Lian S; Wu S; Wang J
Hum Reprod; 1999 Apr; 14(4):970-5. PubMed ID: 10221229
[TBL] [Abstract][Full Text] [Related]
6. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
[TBL] [Abstract][Full Text] [Related]
7. The effect of intrauterine levonorgestrel use on the expression of c-JUN, oestrogen receptors, progesterone receptors and Ki-67 in human endometrium.
Salmi A; Pakarinen P; Peltola AM; Rutanen EM
Mol Hum Reprod; 1998 Dec; 4(12):1110-5. PubMed ID: 9872360
[TBL] [Abstract][Full Text] [Related]
8. Assessment of oestrogen and progestin effects on epithelium and stroma from pre- and postmenopausal endometria.
King RJ; Lane G; Siddle N; Taylor RW; Townsend PT; Whitehead MI
J Steroid Biochem; 1981 Dec; 15():175-81. PubMed ID: 7339244
[TBL] [Abstract][Full Text] [Related]
9. The effect of copper ions in vivo on specific hormonal endometrial receptors.
de Castro A; Gonzalez-Gancedo P; Contreras F; Lapeña G
Adv Contracept; 1986 Dec; 2(4):399-404. PubMed ID: 3551524
[TBL] [Abstract][Full Text] [Related]
10. [Effect of levonorgestrel intrauterine device on human endometrial estrogen and progesterone receptors].
Lu SM
Zhonghua Fu Chan Ke Za Zhi; 1991 Sep; 26(5):293-4, 323. PubMed ID: 1935411
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
[TBL] [Abstract][Full Text] [Related]
12. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
[TBL] [Abstract][Full Text] [Related]
13. Effect of levonorgestrel-releasing intrauterine device on hormonal profile and menstrual pattern after long-term use.
Xiao B; Zeng T; Wu S; Sun H; Xiao N
Contraception; 1995 Jun; 51(6):359-65. PubMed ID: 7554977
[TBL] [Abstract][Full Text] [Related]
14. Pituitary, ovarian and endometrial effects of progesterone released prematurely during the proliferative phase.
Shumin X; Johannisson E; Landgren BM; Diczfalusy E
Contraception; 1983 Feb; 27(2):177-93. PubMed ID: 6851555
[TBL] [Abstract][Full Text] [Related]
15. Effect of estrogen and progestin treatments on endometria from postmenopausal women.
King RJ; Whitehead MI; Campbell S; Minardi J
Cancer Res; 1979 Mar; 39(3):1094-101. PubMed ID: 427751
[TBL] [Abstract][Full Text] [Related]
16. The mechanism of action of the copper intrauterine device.
Tamaya T; Nakata Y; Ohno Y; Nioka S; Furuta N
Fertil Steril; 1976 Jul; 27(7):767-72. PubMed ID: 181276
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of endometrial steroid receptors and cell mitotic activity in women using copper intrauterine device: Can Cu-T prevent endometrial cancer?
Guleria K; Agarwal N; Mishra K; Gulati R; Mehendiratta A
J Obstet Gynaecol Res; 2004 Jun; 30(3):181-7. PubMed ID: 15210039
[TBL] [Abstract][Full Text] [Related]
18. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.
Luukkainen T; Toivonen J
Contraception; 1995 Nov; 52(5):269-76. PubMed ID: 8585882
[TBL] [Abstract][Full Text] [Related]
19. Effects of clomiphene citrate on cytosolic estradiol and progesterone receptor concentrations in secretory endometrium.
Aksel S; Saracoglu OF; Yeoman RR; Wiebe RH
Am J Obstet Gynecol; 1986 Dec; 155(6):1219-23. PubMed ID: 3789035
[TBL] [Abstract][Full Text] [Related]
20. Ovarian function during use of a levonorgestrel-releasing IUD.
Barbosa I; Bakos O; Olsson SE; Odlind V; Johansson ED
Contraception; 1990 Jul; 42(1):51-66. PubMed ID: 2117516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
